Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Sales | 20 | 30 | 160 | 210 | 130 |
| Cost of Goods | 10 | 20 | 40 | 90 | 40 |
| Gross Profit | 10 | 10 | 110 | 130 | 80 |
| Operating Expenses | 740 | 830 | 990 | 1,090 | 750 |
| Operating Income | -720 | -800 | -830 | -880 | -620 |
| Interest Expense | 50 | 40 | 30 | 35 | 20 |
| Other Income | -10 | 10 | -620 | -255 | -80 |
| Pre-tax Income | -780 | -830 | -1,480 | -1,170 | -720 |
| Net Income Continuous | -780 | -830 | -1,480 | -1,170 | -720 |
| Net Income | $-780 | $-830 | $-1,480 | $-1,170 | $-720 |
| EBITDA(a) | $-600 | $-680 | $-650 | $-680 | $-430 |